Skip to main content
RVMD logo
RVMD
(NASDAQ)
Revolution Medicines, Inc.
$99.12-- (--)
Loading... - Market loading

Revolution Medicines, Inc. (RVMD) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Revolution Medicines, Inc. stock.

Analyst Consensus Rating

Investment consensus from 11 professional research analysts

Consensus Rating

Buy
Based on 11 unique analysts
High Confidence:1 Buy/Sell

Average Price Target

$143.73
45.01% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest RVMD Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Clara Dong
Jefferies
Strong BuyInitiates
$88.00 $140.00
Kelsey Goodwin
Piper Sandler
BuyMaintains
$75.00 $120.00
Eva Fortea Verdejo
Wells Fargo
BuyMaintains
$100.00 $144.00
Ami Fadia
Needham
Strong BuyMaintains
$150.00 $145.00
Brian Cheng
JP Morgan
BuyMaintains
$92.00 $122.00
Jay Olson
Oppenheimer
BuyMaintains
$75.00 $150.00
Laura Prendergast
Stifel
Strong BuyMaintains
$85.00 $170.00
Leonid Timashev
RBC Capital
BuyMaintains
$77.00 $140.00
Michael Schmidt
Guggenheim
Strong BuyMaintains
$92.00 $160.00
Joseph Catanzaro
Mizuho
BuyMaintains
$90.00 $143.00
Robert Driscoll
Wedbush
BuyMaintains
$80.00 $147.00

Frequently Asked Questions

What is the analyst consensus rating for RVMD?

The analyst consensus rating for RVMD is "Buy" based on 11 analyst recommendations.

What is the average price target for RVMD?

The average 12-month price target for RVMD is $143.73, representing an upside of 45.0% from the current price of $99.12.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.